Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Annick Laplante
ResearcherPublications, citations & collaboration network
Annick Laplante is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 8 works, 132 citations, an h-index of 2 and an i10-index of 2.
8
Works
132
Citations
2
h-index
2
i10-index
IDs:OpenAlex
How has Annick Laplante's publication output changed over time?
ScholarIQpublication output · 1995–2026
Output grew100% over the shown period — from 1 works in 1995 to 2 in 2026.
1
1
2
1
1
2
199520012020202320252026
What are the most-cited papers on Annick Laplante?
ScholarIQmost cited works
Isotopomer Analysis of Citric Acid Cycle and Gluconeogenesis in Rat Liver
Christine Des Rosiers, Lorella Di Donato, Blandine Comte, Annick Laplante, Caroline Marcoux, France David, Charles A. Fernandez, Henri Brunengraber
S140251998. 1995114 CitationsOPEN ACCESS
Canadian valsartan study in patients with mild-to-moderate hypertension
Ben Lasko, Annick Laplante, Daniel N. Hebert, Sophie Bonnefis-Boyer
S39823226. 200115 Citations
Eight Years of Canadian Real-World Assessment of Tolvaptan in ADPKD: C-MAJOR Study and Safety Monitoring and Distribution Program
Philip A. McFarlane, Daniel G. Bichet, Ahsan Alam, L. E. Bergeron, Sylvie Boutin, Annick Laplante
Journal of the American Society of Nephrology. 20231 Citations
Long-Term Experience of Tolvaptan
Pierre Antoine Brown, Suzy Bubolic, Annick Laplante, Thomas Jaeger, Ahsan Alam
Kidney360. 20251 CitationsOPEN ACCESS
Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry
Philip McFarlane, Daniel G. Bichet, Ahsan Alam, Suzy Bubolic, Annick Laplante
Canadian Journal of Kidney Health and Disease. 20261 CitationsOPEN ACCESS
Related on ScholarIQ
Otsuka Pharmaceutical (Spain)
Institution
Isotopomer Analysis of Citric Acid Cycle and Gluconeogenesis in Rat Liver
Paper
Canadian valsartan study in patients with mild-to-moderate hypertension
Paper
Eight Years of Canadian Real-World Assessment of Tolvaptan in ADPKD: C-MAJOR Study and Safety Monitoring and Distribution Program
Paper
Long-Term Experience of Tolvaptan
Paper
Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry
Paper